NCT02217280View on ClinicalTrials.gov

Dispersal Pattern for Spine Injections (Gadolinium Contrast)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Cervical Radiculopathy
Interventions
DRUG

Injection with Gadolinium

Gadavist (gadobutrol) injection is a gadolinium-based contrast agent indicated for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system

Trial Locations (1)

65212

Missouri Orthopaedic Institute, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT02217280 - Dispersal Pattern for Spine Injections (Gadolinium Contrast) | Biotech Hunter | Biotech Hunter